Global Drug-Device Combination Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Sep 2021
  • Global
  • 350 Pages
  • No of Tables: 188
  • No of Figures: 76

Global Drug-Device Combination Market, By Product (Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens and Others), Application Type (Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, and Others), End User (Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest Of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa and Rest of Middle East And Africa, Brazil and Rest of South America) Industry Trends and Forecast To 2028.

Drug-Device Combination Market Market Analysis and Insights: Global Drug-Device Combination Market

Global drug-device combination market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.2% in the forecast period of 2021 to 2028 and is expected to reach USD 30,854.85 million by 2028. The pandemic outbreak of COVID-19 and growing initiative activities by the government; are the major drivers which propelled the demand of the market in the forecast period.

The increasing prevalence of chronic disease advancement in technology effectively helps the growth of the drug-device combination market. However, the limitations and complications associated with the drug-device combination products may hamper the future growth of the drug-device combination market. The collaboration and partnerships by major market players act as an opportunity. However, strict regulatory framework acts as a challenge for the growth of the global drug-device combination market.

The drug-device combination market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal.

Drug-Device Combination Market Global Drug-Device Combination Market Scope and Market Size

The drug-device combination market is segmented on the basis of product, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of products, the global drug-device combination market is segmented into auto-injector, microneedle patch, digital pill, smart inhaler, drug delivery hydrogels, drug-eluting lens, and others. In 2021, the auto-injector is expected to dominate the global drug-device combination market as the rising demand for medical devices across the globe to treat the patients.
  • On the basis of applications, the global drug-device combination market is segmented into orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, and others. In 2021, the orthopedic is expected to dominate the global drug-device combination market because of the rising geriatric population and rising demand for orthopedic medical devices across the globe to treat patients with bone diseases.
  • On the basis of end-users, the global drug-device combination market is segmented into clinics, hospitals, home care settings, ambulatory care centers, and others. In 2021, the clinics are expected to dominate the global drug-device combination market as they can diagnose disease and take effective longer treatment with the advice of doctors who are experts in a developing country.
  • On the basis of distribution channels, the global drug-device combination market is segmented into direct tender, retail sales, and others. In 2021, the direct tender is expected to dominate the global drug-device combination market as it provides quality, easy and accessible healthcare products. Additionally, direct tender provides the most competitive value from the marketplace.

Drug-Device Combination Market Drug-Device Combination Market Country Level Analysis

The drug-device combination market is analyzed, and market size information is provided by product, application, end user, and distribution channel.

The countries covered in the drug-device combination market report are the U.S., Canada and Mexico, the U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium, and the Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines and rest of Asia-Pacific, South Africa, and Rest of the Middle East and Africa, Brazil.

Auto-injector segment in US is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 owing to growing usage of drug-device combination in numerous treatments. Moreover, the COVID-19 outbreak leads to pursuing home treatment. Japan is the leading country in the growth of the Asia-Pacific market due to escalating technological advancement in healthcare and healthcare devices segments. The auto-injector segment in Germany is dominating the European market owing to the increasing approval of new drug-device combination products.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Growing Strategic Activities by Major Market Players to Enhance the Awareness for Drug-Device Combination Products is Boosting the Market Growth of Drug-Device Combination Market.

The drug-device combination market also provides you with a detailed market analysis for every country's growth in the drug-device combination product industry. Moreover, it provides detailed information regarding Medical devices sales, the impact of regulatory scenarios, and trending parameters regarding the drug-device combination market. The data is available for the historical period 2010 to 2019.

Competitive Landscape and Drug-Device Combination Market Share Analysis

Drug-Device combination market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the drug-device combination market.

The major companies which are dealing in the drug-device combination market are Medtronic, Zimmer Biomet, Amgen Inc., Mediprint, Propeller Health, B.D., YPSOMED, CosMED Pharmaceutical Co.Ltd., Micron Biomedical, Inc., Findair Sp. z o. o., VAXXAS, MetP Pharma AG, SONCEBOZ, Eitan Medical,  Vaxess Technologies Inc., Subcuject Aps, E3D Elcam Drug Delivery Devices, OcuMedic, GlaxoSmithKline plc, Bayer AG, NanoPass, Sensirion AG Switzerland, Janssen Pharmaceuticals, Inc.(a subsidiary of Johnson & Johnson Sevices, Inc.), Insulet Corporation, TheraJect, Otsuka America Pharmaceutical, Inc., Raphas Co., Ltd., EOFLOW CO., LTD., CGbio among others.

Many contracts and agreements are also initiated by companies worldwide, which are also accelerating the drug-device combination market.

For instance,

  • In April 2021, EOFlow Co., Ltd., the US Subsidiary Nephria got a License on the new "MXene" Nanomaterial from Drexel University. Nephria got exclusive rights and planned to develop a wearable dialysis system, otherwise known as the wearable artificial kidney (WAK), starting with this technology transfer. This would accelerate the technologies in the new therapeutic areas and increases the growth of the market.
  • In August 2020, Vaxess Technologies Inc. announced a contract with Biomedical Advanced Research and Development Authority (BARDA) to evaluate alternative vaccination technologies. This increased recognition of their innovative platforms like MIMIX can enable a better response to future pandemics and will boost the market
  • In April 2018, GTRC and Micron Biomedical, Inc. signed an exclusive license agreement. According, to which GTRC granted an exclusive license to microneedle patch technology, and in return, Micron Biomedical, Inc. received exclusive rights to develop, manufacture, sell, use, and sublicense products based on the Georgia Tech technology. This strengthened leadership and increase the market

Collaboration, product launch, business expansion, award and recognition, joint ventures, and other strategies by the market player are enhancing the company's footprints in the drug-device combination market which also provides the benefit for the organization’s profit growth.

Customization Available: Global Drug-Device Combination Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market, and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 GLOBAL DRUG-DEVICE COMIBINATION MARKET, PIPELINE ANALYSIS

TABLE 2 MOST OBESE COUNTRIES OF ASIA-PACIFIC 2020

TABLE 3 GLOBAL DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 4 GLOBAL AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 5 GLOBAL AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 6 GLOBAL MICRONEEDLE PATCH IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 7 GLOBAL DIGITAL PILL IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 8 GLOBAL SMART INHALER IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 9 GLOBAL DRUG DELIVERY HYDROGELS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 10 GLOBAL DRUG-ELUTING LENS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 11 GLOBAL OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 12 GLOBAL DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 13 GLOBAL ORTHOPEDIC DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 14 GLOBAL RESPIRATORY DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 15 GLOBAL DIABETES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL ONCOLOGY IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL CARDIOVASCULAR DISEASES IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 18 GLOBAL OTHERS IN DRUG-DEVICE COMBINATION MARKET, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL CLINICS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL HOSPITALS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL HOME CARE SETTINGS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 GLOBAL AMBULATORY CARE CENTERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL 2019-2028 (USD MILLION)

TABLE 26 GLOBAL DIRECT TENDER IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL RETAIL SALES IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL OTHERS IN DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 GLOBAL DRUG-DEVICE COMBINATION MARKET, BY REGION, 2019-2028 (USD MILLION )

TABLE 30 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 36 U.S. DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 37 U.S. AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 38 U.S. DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 U.S. DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 40 U.S. DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 41 CANADA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 42 CANADA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 43 CANADA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 44 CANADA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 CANADA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 46 MEXICO DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 47 MEXICO AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 48 MEXICO DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 MEXICO DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 50 MEXICO DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 51 EUROPE DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 52 EUROPE DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 53 EUROPE AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 54 EUROPE DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 55 EUROPE DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 56 EUROPE DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 57 GERMANY DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 58 GERMANY AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 59 GERMANY DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 GERMANY DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 61 GERMANY DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 62 FRANCE DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 63 FRANCE AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 64 FRANCE DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 65 FRANCE DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 66 FRANCE DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 67 U.K. DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 68 U.K. AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 69 U.K. DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 70 U.K. DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 71 U.K. DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 72 ITALY DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 73 ITALY AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 74 ITALY DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 ITALY DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 76 ITALY DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 77 SPAIN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 78 SPAIN AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 79 SPAIN DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 80 SPAIN DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 SPAIN DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 82 RUSSIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 83 RUSSIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 84 RUSSIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 85 RUSSIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 86 RUSSIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 87 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 88 SWITZERLAND AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 89 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 90 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 91 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 92 TURKEY DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 93 TURKEY AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 94 TURKEY DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 95 TURKEY DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 96 TURKEY DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 97 BELGIUM DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 98 BELGIUM AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 99 BELGIUM DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 100 BELGIUM DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 101 BELGIUM DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 102 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 103 NETHERLANDS AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 104 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 106 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 107 REST OF EUROPE DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 108 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 109 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 110 ASIA-PACIFIC AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 111 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 112 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 113 ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 114 JAPAN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 115 JAPAN AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 116 JAPAN DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 117 JAPAN DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 JAPAN DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 CHINA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 120 CHINA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 121 CHINA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 122 CHINA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 123 CHINA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 124 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 125 SOUTH KOREA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 126 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 127 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 128 SOUTH KOREA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 129 INDIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 130 INDIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 131 INDIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 132 INDIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 133 INDIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 134 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 135 AUSTRALIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 136 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 137 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 138 AUSTRALIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 139 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 140 SINGAPORE AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 141 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 142 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 143 SINGAPORE DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 144 THAILAND DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 145 THAILAND AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 146 THAILAND DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 147 THAILAND DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 148 THAILAND DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 149 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 150 MALAYSIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 151 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 152 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 153 MALAYSIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 154 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 155 INDONESIA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 156 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 157 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 158 INDONESIA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 159 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 160 PHILIPPINES AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 161 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 162 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 163 PHILIPPINES DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 164 REST OF ASIA-PACIFIC DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 165 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 166 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 167 SOUTH AMERICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 168 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 169 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 170 SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 171 BRAZIL DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 172 BRAZIL AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 173 BRAZIL DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 174 BRAZIL DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 175 BRAZIL DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 176 REST OF SOUTH AMERICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 177 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 178 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 179 MIDDLE EAST AND AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 180 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 181 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 182 MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 183 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 184 SOUTH AFRICA AUTO-INJECTOR IN DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 185 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 186 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 187 SOUTH AFRICA DRUG-DEVICE COMBINATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 188 REST OF MIDDLE EAST AND AFRICA DRUG-DEVICE COMBINATION MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions